Animal model of neuronal injury

a neuronal injury and animal model technology, applied in the field of animal models of neuronal injury, can solve the problems of inability to perform rapid pharmacodynamics studies, and achieve the effect of easy creation

Active Publication Date: 2015-10-22
THE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADS
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present inventors have developed new methods for making animals with specific brain structures without requiring any genetic modifications or adjustments made by others during their development process. This results in improved understanding about how these organisms develop neurologically important parts such as motor control systems (MCS) which are involved in diseases like Parkinson's Disease.

Problems solved by technology

The technical problem addressed by this patents relates to developing novel ways to study neural damage caused by diseases such as Alzheimer' s disease or Parkinsonism due to changes induced during normal aging processes associated with those conditions. Current treatments involve either relying solely upon symptoms alone or drugs like cholinesterase inhibitors, both having potential harmful consequences if administered incorrectly. Therefore it would benefit from more accurate simulations involving complex interactions between different factors involved in nerve degenerating disorders.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Animal model of neuronal injury
  • Animal model of neuronal injury
  • Animal model of neuronal injury

Examples

Experimental program
Comparison scheme
Effect test

example 1

Induction of Cognitive Decline and Decreased Memory Recall by Chronic lntracerebroventricular infusion (ICV) of Fibrinogen to the CNS of a Mammal

[0107]Fibrinogen was delivered to the central nervous system (CNS) of wild-type mice by ICY. Briefly, fibrinogen (5 mg / ml) or artificial cerebrospinal fluid (ACSF), a control, was infused into the CNS of the mice using 14-day Alzet pumps through a cannula implanted in the right lateral ventricle. The concentration of the fibrinogen solution was selected based on its physiological range in the plasma. Five days after pump implantation, the mice were trained in the Morris water maze and tested after removal of the target platform 24 hours after the last learning trial. Fibrinogen-infused mice had impaired memory recall, as exhibited by no difference in the number of crossings of the target platform (FIG. 1A) or time spent in the target quadrant (FIG. 1B) The ACSF-infused control mice crossed the target platform significantly more times and als

example 2

Induction of Neuronal Damage and Cognitive Decline by Injection of Fibrinogen in the Dentate Gyrus of a Mammalian Brain

[0109]To assess the effect of an increase in the local concentration of fibrinogen in a specific region of interest in the brain, mice received a single stereotactic injection of either 5 μg fibrinogen (1 μl of 5 mg / ml fibrinogen) or 1 μl control (ACSF) in the dentate gyrus. The effects on memory retrieval were assessed in the contextual fear conditioning test (Riley C et al., (2012) Expert review of neurotherapeutics 12(3):323-333.). Mice were placed in a novel environment and given a brief foot shock (training day; day 6 post injection). Memory was assessed by placing the mice in the same environment again one day after the training day (testing day, day 7 post-injection) and freezing (anxiety) behavior was recorded. Percentage of freezing is a direct measure of memory retrieval. Fibrinogen injected animals presented a significant decrease in percentage of freezing

example 3

Reduction of Dendritic Spine Density by Injection of Fibrinogen in the Cortex of a Mammalian Brain

[0112]Fibrinogen injection in the cortex reduces dendritic spine density. Dendritic spines are the major site of excitatory synaptic inputs in the brain (Nimchinsky EA, et al., Annu Rev Physiol. 64:313-353). Novel spine formation and pre-existing spine elimination reflect the structural consequences of dynamic changes in neuronal activity at the cellular level (Grutzendler J & Gan WB (2006) NeuroRx 3(4):489-496; Trachtenberg J T et al., (2002) Nature 420(6917):788-794; Grutzendler J et al. (2002) Nature 420(6917):812-816.). Thus, dynamic changes in spine numbers and morphology are considered the cellular mechanisms underlying memory and learning (Holtmaat Aet al. (2006) Nature 441 (7096):979-983). To assess the effect of a local concentration of fibrinogen on spine morphology, we injected fibrinogen by stereotactic injection into the cortex, and the brains were examined 3 days later by Gol

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides non-human animal models of neuronal injury and/or cognitive dysfunction and methods of making and using such animal models. The animal models of the invention are particularly suited to assessing neurodegeneration in selected regions of interest in the CNS, and thus especially useful for testing the therapeutic efficacy of agents targeting neurodegeneration associated with aging, neurodegenerative diseases, autoimmunity and trauma (e.g., ischemia).

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner THE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products